Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.

Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...

In addition to vitiligo, Mini also works with cancer survivors, helping to reconstruct areolas post-mastectomy, and individuals with burn scars or surgical marks. Her approach is deeply personal, ...

The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for ...

China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on September 24, 2024, the New Drug Application (NDA) for ...

The biotech startup will use the funds to assist its Phase II human clinical trials for its drug candidate for vitiligo.

Celebrating the success of the Albinism Society of South Africa (ASSA) fundraising event held at Birchwood Hotel recently are ...

Drug maker AbbVie (ABBV) announced Wednesday positive results from a new post-hoc analysis of Phase 3 Studies, demonstrating efficacy ...

We often view celebrities as flawless beings due to their access to makeup, glam squads, and even cosmetic surgeries. Ho ...

Janet Jackson is being called “irrelevant” and a “leech” after she questioned Kamala Harris’ race in an interview with the ...